FDAnews Announces — Taming the Supply Chain Data Beast: Compliance with the Drug Supply Chain Act through Better Data Quality Webinar, July 23, 2015

Share Article

On May 1 the Drug Supply Chain Security Act (DSCSA) went into effect for drug manufacturers, wholesalers and repackagers. GS1 US’s Senior VP Siobhan O’Bara, the recognized world leader in data quality, will walk webinar attendees through the steps necessary to not only ensure the quality of supply chain data but also how to facilitate sharing that data with partners.

Taming the Supply Chain Data Beast:
Compliance With the Drug Supply Chain Act Through Better Data Quality
**FDAnews Webinar**
July 23, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/supplychaindata

On May 1 the Drug Supply Chain Security Act (DSCSA) went into effect for drug manufacturers, wholesalers and repackagers.

The Act requires that at every step of the drug supply chain, from factories to finished products to pharmacies, data from the supplier and the recipient must match perfectly or the entire batch will be quarantined until the discrepancy can be resolved. This raises a significant possibility of lost time and money for drug manufacturers.

The bottom line is manufacturers can no longer afford to have the supply chain disrupted by data problems.

GS1 has emerged as the solutions provider in this area. GS1 estimates between $2 and $5 billion can be saved annually across the drug industry through efficiency improvements.

Let GS1 US’s Senior VP Siobhan O’Bara, the recognized world leader in data quality, walk manufacturers through the steps necessary to not only ensure the quality of the supply chain data but also how to facilitate sharing that data with partners.

In 90 minutes attendees will learn:

  • How to completely comply with the 2015 DSCSA requirements. Plus, the even stricter 2017 and 2023 requirements.
  • Tips and tricks to assure manufacturers have the correct data in the event of a recall. Recalls are costly, headache inducing and hurt a businesses’ reputation. Having the right data to eliminate these problems is crucial.
  • Can manufacturers confidently say they can thwart counterfeit versions of their products entering the supply chain?
  • How GS1’s systems allow manufacturers to trace a single bottle all the way from the factory to a patient (one major manufacturer has collected data on over 4 million bottles!)

Meet the Presenter:
Siobhan O’Bara, Sr. Vice President, Industry Engagement at GS1 US
Siobhan O’Bara has worked in logistics, supply chain and customer operations management at global healthcare companies for over 20 years. Over the course of her career, she has established a track record of successful change management, business development, and project/program management, while building high-performing teams and uniting cross functional teams within the organization, and has a reputation in the industry as a thought leader in supply chain re-engineering. Currently, she is the Senior Vice President of Industry Engagement for GS1 US, where she builds industry relationships through strategic and meaningful collaboration. Before assuming this role, she was GS1 US’s Vice President of Healthcare, where she was responsible for setting strategy and ensuring achievement of operating results for GS1 Healthcare US, including supporting GS1 Standards implementation initiatives across the United States healthcare industry.

Who Will Benefit:

  • Executive Management
  • Regulatory Managers
  • Labeling Specialists
  • Project Managers
  • Quality Managers
  • Executive Management
  • R&D Staff
  • Strategic Planning Staff
  • Pharmaceutical and cGMP auditors
  • Risk management specialists
  • Compliance officers

Conference Details:
Taming the Supply Chain Data Beast:
Compliance With the Drug Supply Chain Act Through Better Data Quality
**FDAnews Webinar**
July 23, 2015 — 1:30 p.m. – 3:00 p.m. EDT
http://www.fdanews.com/supplychaindata

Tuition:
$287 per site

Easy Ways to Register:
Online: http://www.fdanews.com/supplychaindata
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website